Key Takeaways
- Double-digit margins achieved, but Q4 flattered by one-offs: EBITDA margin hit double digits for the first time, yet ~250 bps came from non-recurring purchase price variance claims. The underlying sustainable run-rate is still double-digit, just lower than the headline.
- The large defense drag is finally gone: A multi-year Indian defense program that once made up 25–30%+ of revenue and diluted margins has ended. Its removal is a structural tailwind for profitability, even as it creates a near-term revenue hole.
- Altek integration complete; US operations now a real pipeline driver: The acquisition is fully integrated, and the Connecticut facility has already generated at least nine active opportunities from existing India-based clients who previously lacked a US option.
- Order backlog is declining, and management won't give guidance: Backlog fell QoQ as the large Indian program wound down. Management declined to provide full-year growth targets, citing a business where "one deal can quickly change everything."
- What to watch next quarter: Whether the "soft start to FY '26" materializes as a shallow dip or something deeper, the pace of new order backlog rebuilding, and any conversion of the nine US opportunities into announced wins.
The Margin Reset: What's Real and What's Not
- One-off tailwinds: Purchase price variance claims from customers, which are typically spread through the year, concentrated in Q4 and added ~250 bps to margins. These are not quarterly events.
- Sustainable base: Even stripping out those claims, Q4 margins were double-digit. Management expects full-year FY '26 margins to land in the 10–12% range, with seasonality within the year.
- Structural lift from mix: The exit of the large, margin-dilutive Indian defense program (25–30%+ of revenue in some quarters) is now flowing through. The revenue mix is shifting toward higher-margin work.
- Interest cost tailwind: Debt doubled to fund the Altek acquisition, but interest cost stayed flat because dollar debt is tied to low SOFR rates. Loan restructuring toward PCFC loans (leveraging net exporter status) should reduce interest cost further in FY '26.
Kulkarni: "Our Q4 margins are high due to a couple of one-off tailwinds that we received during the quarter... from a quarterly sustainable number, we should take out about 250 basis points from these numbers to see where we will land in future at these volumes."
The Defense Hole and the Rebuild
- What ended: A 2.5-year program for a large Indian defense client, which consumed significantly more than the intake rate, driving the backlog decline. The program was margin-dilutive, so its end is a net positive for profitability.
- What comes next: If the Ministry of Defense issues a renewal RFP, Cyient DLM is well-positioned as the incumbent who successfully delivered the first lot. The program could ramp quickly since manufacturing capability is already in place. But there could be a time gap before any new order.
- Backlog trajectory: Management is "very confident" of rebuilding the backlog, citing a robust pipeline expected to convert quickly. The decline should start reversing, though no specific half was committed to.
- The wildcard: Even one large order can change the dynamics entirely, which is precisely why management refuses to give full-year guidance.
Kulkarni: "This is a business that is not at a level of stability where we can really predict. One deal can quickly change everything, right?"
US Operations: The Connecticut Option
- Pipeline from existing clients: At least nine separate discussions are underway with current India-based clients who are eager to use the US manufacturing option, quoting new products they previously couldn't access.
- Two-way opportunity: The US facility also opens discussions to provide Altek's existing US clients with an offshore option through India, creating a cost-effective hybrid model.
- Revenue timing: Wins announced in the coming quarter would start converting to revenue toward the later part of FY '26, though some transfer programs could convert more quickly.
- Tariff backdrop: The US tariff environment is reinforcing the China Plus One trend, with diversifying supply chains remaining a strong part of client strategies. Management sees this as a tailwind for the Connecticut facility.
Montalbano: "we have, I'd say, at least nine separate discussions, nine separate opportunities we're looking at that are just simply from our current clients that we are supporting in India today. Very eager to have learned that we now have a US option and so we're now quoting new products that really we didn't have access to before."
Portfolio Mix Shift
| Segment | Trend | Commentary |
|---|---|---|
| Aerospace | ▲ Strong growth | Up 53% YoY, driven by top customers. |
| Defense | ▼ Declining | The large Indian program ended; European defense clients are among the top five growth accounts heading into FY '26. |
| Medical | ▲ Growing share | Now 35% of the portfolio post-Altek; new medical logos are ramping to manufacturing faster than A&D programs. |
| Industrial | ▲ Growing share | 14% of portfolio post-Altek; also seeing faster new-logo ramp cycles. |
| Export vs India | ▬ Shifting | Mix likely moving to 80-20 (rest of world vs India) as the large domestic program ends and most backlog to be serviced is export. |
- New logo quality: Five of the six new logos added in FY '25 are very large multinational A-list companies. Any one has the potential to become a $50 mn+ annual client as the business scales.
- One logo is different: One new logo is bringing entirely new product and technology to market and will start impacting revenue in FY '26 itself.
- A&D logos take longer: New logos in aerospace & defense and energy services have significant long-term potential but may not contribute meaningfully to FY '26 revenue; order book and backlog will start building first.
Montalbano: "Any one of these clients has the opportunity to be $50 million plus a year type of client for us as we build and scale the business with them."
Balance Sheet and Cash Flow
- Working capital: Net working capital days rose from 120 to 127 QoQ, but DIO reduced by 6 days and customer advances increased by 6 days, helping generate positive operating cash of ₹53 crore for the quarter.
- FY '26 target: Management is targeting positive operating cash flow for the full year, with initiatives on DSO, DIO, and DPO playing out well.
- Capex: Substantially underutilized because not much was spent in the last couple of years; may take a year or two to complete.
- Fair value hit: A ~₹35 crore adjustment flowed through other comprehensive income due to a drop in valuation of an investee defense technology company whose orders have "right shifted." This is non-cash and below the PAT line.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| EBITDA margin | Double-digit on a full-year basis; analyst range of 10–12% was not disputed | FY '26 |
| Operating cash flow | Positive | FY '26 |
| Order backlog | Reversal of the declining trend | No date given |
| Interest cost | Reduction due to loan restructuring toward PCFC loans | FY '26 |
| Revenue mix | 80-20 rest of world vs India | FY '26 |
| US operations revenue | Wins announced in coming quarter convert to revenue | Latter part of FY '26 |
| Large defense program renewal | Depends on Ministry of Defense issuing an RFP; company well-positioned as incumbent | No timeline (external trigger) |
Key Metrics
| Metric | Q4 FY25 |
|---|---|
| Revenue | ₹428.1 cr, +18.3% YoY |
| Standalone revenue | ₹340.3 cr, -5.9% YoY |
| EBITDA | ₹57.4 cr, +50.9% YoY |
| EBITDA margin | 13.4%, +290 bps YoY; includes ~250 bps of one-off tailwinds from purchase price variance claims |
| PAT | ₹31 cr, +36.5% YoY; highest profit in 12 quarters since IPO |
| PAT margin | 7.3%, +96 bps YoY |
| Full-year revenue | ₹1,519.6 cr, +27.5% YoY |
| Full-year adjusted EBITDA | ₹145.2 cr, +30.8% YoY |
| Full-year adjusted EBITDA margin | 9.6%, +24 bps YoY; target was 10% |
| Full-year PAT | ₹74 cr, +21% YoY |
| Order backlog | ₹1,906 cr, declined QoQ; large Indian defense program concluded |
| Net working capital | 127 days, up from 120 days QoQ |
| Operating cash flow | ₹53 cr positive cash generated in Q4 |
| Capacity utilization | ~60% overall; higher in Mysore, lower in other plants |
| New logos added | 6 in FY25; 5 of 6 are large multinational A-list companies |
| Top 5 client concentration | ~80% of revenue, expected to continue next year |
| Aerospace segment growth | 53% YoY, driven by top customers |
| Industry mix | 35% medical, 14% industrial; more balanced portfolio post-Altek acquisition |
| IPO proceeds utilized | 76.6%; ~₹115-120 cr remaining for incremental working capital |